Description
This medication is available by prescription only and requires a veterinarian/patient relationship.
Therapeutic Monitoring Schedule:
Exam every 6 months unless indicated otherwise by doctor
The only oral solution product approved by the FDA for managing congestive heart failure due to myxomatous mitral valve disease or dilated cardiomyopathy in dogs
